Denali Therapeutics
DNLI
DNLI
203 hedge funds and large institutions have $3.18B invested in Denali Therapeutics in 2023 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 84 increasing their positions, 55 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
8% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 25
0% more funds holding
Funds holding: 202 → 203 (+1)
0.17% less ownership
Funds ownership: 79.04% → 78.86% (-0.17%)
Holders
203
Holding in Top 10
4
Calls
$1.23M
Puts
$416K
Top Buyers
| 1 | +$54.2M | |
| 2 | +$18.6M | |
| 3 | +$15M | |
| 4 |
Man Group
London,
United Kingdom
|
+$14.9M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$14.8M |
Top Sellers
| 1 | -$55.3M | |
| 2 | -$38.9M | |
| 3 | -$15M | |
| 4 |
Barclays
London,
United Kingdom
|
-$14.7M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$11.5M |